A new report urges equitable development and oversight of AI in neurological imaging to avoid worsening healthcare disparities.
Key Details
- 1UCLA Health and collaborators published a Neurology journal report assessing AI's dual impact in neurological care.
- 2AI already aids doctors in classifying brain tumors and stroke imaging for faster decisions.
- 3Researchers highlight risks for bias due to underrepresentation of certain groups in datasets.
- 4Three guiding principles recommended: diverse stakeholder input, AI education for neurologists, and strong independent governance.
- 5The aim is for AI to advance equity, particularly in resource-limited and underrepresented communities.
- 6The literature review involves experts from healthcare, FDA, and AI industry.
Why It Matters

Source
EurekAlert
Related News

AI Accelerates Radiopharmaceuticals, Boosts Personalized Dosimetry in Cancer
Machine learning is driving advancements in radiopharmaceutical drug discovery and optimizing patient-specific dosimetry for precision cancer therapy.

Physicians Overly Trust Erroneous AI, Ignore Contradictory Evidence
Physicians tend to trust incorrect AI advice, even when evidence contradicts it, suggesting risks in clinical decision-making with AI tools.

Concerns Raised Over Unverified Datasets in AI Health Prediction Models
A new study finds widely used AI health prediction models are built on datasets with unverifiable origins, raising safety and validity concerns.